Devax, Inc.
Irvine
California
United States
6 articles about Devax, Inc.
-
Devax, Inc. Receives CE Mark for the AXXESS Drug Eluting Bifurcation Stent
7/29/2010
-
Medical Device Company Devax, Inc. Withdraws IPO Plans
12/14/2007
-
Devax, Inc. Announces Completion of Enrollment of DIVERGE Trial of Novel Drug
12/12/2007
-
Devax, Inc. Files for $85 Million IPO
5/4/2007
-
Devax, Inc. Initiates Enrollment In The DIVERGE Clinical Trial With The AXXESS(TM) Drug Eluting Bifurcation Stent System
6/21/2006
-
Devax, Inc. Closes On $32 Million Of Series D Financing
11/2/2005